NEULANDLABNSEQ4 FY 2026April 29, 2026

Neuland Laboratories Limited

311words
3turns
0analyst exchanges
0executives
Key numbers — 1 extracted
rs,
April 29, 2026 To BSE Limited Phiroze Jeejeebhoy Towers, 25th Floor, Dalal Street, Mumbai – 400 001 The National Stock Exchange of India Ltd Exchange Pla
Speaking time
Time
1
For Diamond Pass Registration Please Click Here
1
For more queries please contact
1
Opening remarks
For Diamond Pass Registration Please Click Here
Diamond Pass About Neuland Laboratories Limited (BSE:524558, NSE: NEULANDLAB) For over 4 decades, Neuland Labs has been at the forefront of manufacturing APIs through its cGMP manufacturing facilities, working with customers in close to 80 countries. Neuland Labs has developed more than 300 processes and 100 APIs and has filed around 995+ Regulatory filings in the US (75 active US DMFs), the European Union (EU) and other geographies. Its record of quality manufacturing and reliability is highlighted by cGMP certifications that include the U.S. FDA, TGA (Australia), EDQM (EU), German Health Authority, ANVISA (Brazil), EMA (EU), Cofepris (Mexico), KFDA (Korea), PMDA (Japan), CFDA (China), FSI “SID & GP” Russia, Health Canada, ISO 9001, ISO14001, OHSAS18001 and ISO 27001. For more information, visit www.NeulandLabs.com
For more queries please contact
Neuland: ir@neulandlabs.com Ravi Udeshi: ravi.udeshi@in.ey.com Minakshi Machutre: Minakshi.machutre@in.ey.com
← All transcriptsNEULANDLAB stock page →